GHK-Cu is a copper-binding tripeptide composed of glycine, histidine, and lysine (Gly-His-Lys) complexed with a divalent copper ion (Cu²⁺). First isolated from human plasma in 1973, the peptide has been studied for decades across wound healing, cellular signaling, gene expression, and extracellular matrix research. This article summarizes what peer-reviewed literature indicates so far about how the tripeptide-copper complex behaves in laboratory research, and how its distribution is investigated.

What Is GHK-Cu?

GHK refers to the copper complex formed when the tripeptide glycyl-L-histidyl-L-lysine (GHK) coordinates with a Cu²⁺ ion. The free tripeptide was first isolated from human plasma by Loren Pickart in 1973, who observed that plasma from younger donors contained higher concentrations of the tripeptide than plasma from older donors.

Structural Properties

• Amino acid sequence: Glycine → L-Histidine → L-Lysine
• Molecular formula (peptide): C₁₄H₂₄N₆O₄
• Peptide molecular weight: ~340.39 g/mol
• Copper-bound complex molecular weight: ~402.9 g/mol (approximate, with Cu²⁺ coordination)
• CAS number (GHK-Cu): 49557-75-7

The copper coordination geometry is what distinguishes GHK-Cu from the uncomplexed tripeptide. Research has examined this complex as an analytically distinct species from the free tripeptide, with different bioavailability behavior, structural stability, and affinity for cellular receptors and matrix components in reported in-vitro systems.

How Does GHK-Cu Work in Research Models?

Research published over the past few decades has investigated multiple pathways through which GHK-Cu has been shown to act in pre-clinical and in-vitro systems. The mechanism of interest is multifaceted and is typically described in the literature across four categories.

1. Copper Ion Transport

In cell cultures and old-free systems, the GHK carrier has been studied for its role in shuttling Cu²⁺ into cells and tissues, and for supporting oxidase and superoxide dismutase activities. Researchers have characterized this as a physiological copper-delivery function rather than a pharmacological one.

2. Modulation of Gene Expression

Gene-expression profiling studies have examined GHK-Cu's interaction with transcriptional programs in fibroblast and keratinocyte models. In one of the most widely cited datasets, GHK was reported to modulate the expression of more than 4,000 genes in fibroblasts, affecting pathways related to extracellular-matrix production, antioxidant defense, and cellular-stress response elements.

3. Extracellular Matrix Research

In fibroblast cultures, the GHK-Cu complex has been studied for its effects on type I collagen synthesis and matrix remodeling. Reported extracellular-matrix collagen synthesis in fibroblast cultures with the tripeptide-copper complex, relative to controls, has been surveyed extensively across the literature.

4. Antioxidant and Cellular Stress Research

In vitro research has examined GHK-Cu's interactions with reactive oxygen species and its potential to chelate redox-active metal ions. These studies are conducted in cell-free and cell-culture systems and do not constitute evidence of any effect on human subjects.

Why the Copper Component Matters Analytically

GHK as a free tripeptide and GHK-Cu as a copper complex are distinct analytical species. For research contexts where a study protocol specifies the copper complex, verifying the copper component is in fact the complexed form — not the free tripeptide — is a methodological requirement.

Analytically, the copper complex can be distinguished from free GHK through:

• UV-Vis spectroscopy: GHK-Cu has a characteristic d-d transition absorbance near 525 nm, absent in the uncomplexed peptide.
• HPLC retention behavior: The copper complex elutes differently from the free tripeptide on reverse-phase C18 columns.
• Mass spectrometry: The mass shift corresponding to Cu²⁺ incorporation is directly observable.

A supplier that does not publish HPLC and mass spectrometry verification for a GHK-Cu batch cannot confirm to a researcher that the vial contents are the complexed form at the stated stoichiometry. This is one of the reasons published batch-level COAs are a meaningful signal in peptide research procurement.

Verifying Research-Grade GHK-Cu Purity

Research-grade GHK-Cu certification of OPTMZ Peptides is conducted through a third-party laboratory — Kraya Analytical, a DEA-registered, ISO/IEC 17025-certified laboratory based in Austin, Texas. Every batch is tested across the following methods before release:

1. Reverse-phase HPLC — purity quantification. Batches below 98% are rejected.
2. Mass spectrometry — identity confirmation, including verification of Cu²⁺ complexation.
3. Endotoxin (LAL) — bacterial endotoxin quantification.
4. Heavy metals (ICP-MS) — detection of non-specified metal contamination.
5. Microbial testing — total aerobic and yeast/mold counts.
6. pH stability — reconstitution behavior.
7. Visual inspection — lyophilized cake color, uniformity, and clarity.

Typical GHK-Cu batch results fall in the 98.5–99.9% purity range by HPLC. Batch-specific results are published in the OPTMZ COA Vault, searchable by the batch number printed on each vial.

Reading a GHK-Cu Certificate of Analysis

A complete GHK-Cu COA from an OPTMZ 17025 laboratory includes:

• Batch number (matched to the vial label)
• Test date and release date
• HPLC purity confirmation with chromatogram
• Mass spectrometry identification (expected vs. observed ion)
• Endotoxin result (EU/mg)
• Heavy metals result (Pb, As, Cd, Hg by ICP-MS)
• Microbial result
• Testing laboratory name, address, and accreditation number
• Analyst signature and reviewer signature

Research-Grade vs. Cosmetic-Grade GHK-Cu

GHK-Cu is sold across two distinct market classifications with meaningfully different verification standards:

• Cosmetic-grade GHK-Cu is formulated into topical skincare products (serums, creams), blended intentionally with excipients for use in personal care formulations. Purity is regulated as an ingredient, not as an isolated analytical compound.
• Research-grade GHK-Cu is supplied as a lyophilized powder, intended exclusively for in-vitro laboratory research by qualified professionals. Research-grade material is accompanied by a Certificate of Analysis and identifies verifiable, batch-specific lab confirmation.

OPTMZ Peptides supplies research-grade material only. It is not a cosmetic ingredient supplier, and its GHK-Cu product listing is intended for qualified researchers and authorized laboratories that verify third-party purity data before ordering.

Stability and Handling in Research Settings

Lyophilized GHK-Cu, when stored under appropriate conditions, has been reported in the analytical literature to retain purity over extended timeframes. Standard research handling conditions are:

• Unopened lyophilized vial: store at -20°C, protected from light.
• Reconstituted material: store at 2-8°C; typical research stability window of 14-30 days in bacteriostatic water, per literature-referenced conditions.
• Reconstitution solvent: bacteriostatic water (0.9% benzyl alcohol) is standard for research protocols; sterile water for injection is used where preservative-free reconstitution is required.
• Freeze-thaw cycles: repeated freeze-thaw cycles have been documented to accelerate degradation in stability studies. Solutions should be aliquoted in a single-use quantity where possible.

How OPTMZ Peptides Verifies Every GHK-Cu Batch

OPTMZ Peptides maintains a verified First-mail model: no claim on the site is made that is not backed by publishable, batch-level testing data. For each GHK-Cu batch, specifically:

• Every inventory batch is independently tested prior to release. Batches falling below 98% purity are discarded and not sold.
• The Certificate of Analysis for each batch is published to the COA Vault, searchable by batch number before the batch is offered for sale.
• The testing methodology is documented publicly on the How We Test page.
• Historical COAs remain available after a batch's sell-through — the archive component allows researchers to do a queryable batch-level lookup as a standard supplier practice.
• OPTMZ additionally operates a third-party testing account, accepting complete random samples from researchers who wish to independently verify their purchased supply.

For researchers evaluating whether to incorporate a given supplier's GHK-Cu into a published research protocol, this documentation standard is the primary signal that distinguishes verified research-grade material from unverified supply.